Literature DB >> 22558104

Replication, neurotropism, and pathogenicity of avian paramyxovirus serotypes 1-9 in chickens and ducks.

Shin-Hee Kim1, Sa Xiao, Heather Shive, Peter L Collins, Siba K Samal.   

Abstract

Avian paramyxovirus (APMV) serotypes 1-9 have been isolated from many different avian species. APMV-1 (Newcastle disease virus) is the only well-characterized serotype, because of the high morbidity, mortality, and economic loss caused by highly virulent strains. Very little is known about the pathogenesis, replication, virulence, and tropism of the other APMV serotypes. Here, this was evaluated for prototypes strains of APMV serotypes 2-9 in cell culture and in chickens and ducks. In cell culture, only APMV-1, -3 and -5 induced syncytium formation. In chicken DF1 cells, APMV-3 replicated with an efficiency approaching that of APMV-1, while APMV-2 and -5 replicated to lower, intermediate titers and the others were much lower. Mean death time (MDT) assay in chicken eggs and intracerebral pathogenicity index (ICPI) test in 1-day-old SPF chicks demonstrated that APMV types 2-9 were avirulent. Evaluation of replication in primary neuronal cells in vitro as well as in the brains of 1-day-old chicks showed that, among types 2-9, only APMV-3 was neurotropic, although this virus was not neurovirulent. Following intranasal infection of 1-day-old and 2-week-old chickens, replication of APMV types 2-9 was mostly restricted to the respiratory tract, although APMV-3 was neuroinvasive and neurotropic (but not neurovirulent) and also was found in the spleen. Experimental intranasal infection of 3-week-old mallard ducks with the APMVs did not produce any clinical signs (even for APMV-1) and exhibited restricted viral replication of the APMVs (including APMV-1) to the upper respiratory tract regardless of their isolation source, indicating avirulence of APMV types 1-9 in mallard ducks. The link between the presence of a furin cleavage site in the F protein, syncytium formation, systemic spread, and virulence that has been well-established with APMV-1 pathotypes was not evident with the other APMV serotypes.

Entities:  

Mesh:

Year:  2012        PMID: 22558104      PMCID: PMC3340391          DOI: 10.1371/journal.pone.0034927

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  39 in total

Review 1.  Newcastle disease and other avian paramyxoviruses.

Authors:  D J Alexander
Journal:  Rev Sci Tech       Date:  2000-08       Impact factor: 1.181

2.  The isolation of yucaipa-like paramyxoviruses from epizootics of a respiratory disease in turkey poultry farms in Israel.

Authors:  M A Lipkind; Y Weisman; E Shihmanter; D Shoham; A Aronovici
Journal:  Vet Rec       Date:  1979 Dec 22-29       Impact factor: 2.695

3.  The rule of six, a basic feature for efficient replication of Sendai virus defective interfering RNA.

Authors:  P Calain; L Roux
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

4.  Effect of paramyxovirus yucaipa on fertility, hatchability, and poult yield of turkeys.

Authors:  R A Bankowski; J Almquist; J Dombrucki
Journal:  Avian Dis       Date:  1981 Apr-Jun       Impact factor: 1.577

5.  Mutation of the f-protein cleavage site of avian paramyxovirus type 7 results in furin cleavage, fusion promotion, and increased replication in vitro but not increased replication, tissue tropism, or virulence in chickens.

Authors:  Sa Xiao; Sunil K Khattar; Madhuri Subbiah; Peter L Collins; Siba K Samal
Journal:  J Virol       Date:  2012-01-18       Impact factor: 5.103

6.  Isolation of a new avian paramyxovirus from budgerigar (Melopsittacus undulatus).

Authors:  K Nerome; M Nakayama; M Ishida; H Fukumi
Journal:  J Gen Virol       Date:  1978-02       Impact factor: 3.891

7.  Phylogenetic relationships among virulent Newcastle disease virus isolates from the 2002-2003 outbreak in California and other recent outbreaks in North America.

Authors:  Janice C Pedersen; Dennis A Senne; Peter R Woolcock; Hailu Kinde; Daniel J King; Mark G Wise; Brundaban Panigrahy; Bruce S Seal
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

8.  Distribution and trafficking of JHM coronavirus structural proteins and virions in primary neurons and the OBL-21 neuronal cell line.

Authors:  J M Pasick; K Kalicharran; S Dales
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

9.  A hitherto unreported paramyxovirus of turkeys.

Authors:  B Tumova; J H Robinson; B C Easterday
Journal:  Res Vet Sci       Date:  1979-09       Impact factor: 2.534

10.  Roles for the cytoplasmic tails of the fusion and hemagglutinin-neuraminidase proteins in budding of the paramyxovirus simian virus 5.

Authors:  David L Waning; Anthony P Schmitt; George P Leser; Robert A Lamb
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

View more
  21 in total

1.  Role of C596 in the C-terminal extension of the haemagglutinin-neuraminidase protein in replication and pathogenicity of a highly virulent Indonesian strain of Newcastle disease virus.

Authors:  Shin-Hee Kim; Sa Xiao; Anandan Paldurai; Peter L Collins; Siba K Samal
Journal:  J Gen Virol       Date:  2013-11-06       Impact factor: 3.891

2.  Evaluation of the genetic diversity of avian paramyxovirus type 4.

Authors:  Baibaswata Nayak; Shreeraj Nayak; Anandan Paldurai; Sachin Kumar; Roberta De Nardi; Calogero Terregino; Peter L Collins; Siba K Samal
Journal:  Virus Res       Date:  2012-11-21       Impact factor: 3.303

3.  Highly divergent virulent isolates of Newcastle disease virus from the Dominican Republic are members of a new genotype that may have evolved unnoticed for over 2 decades.

Authors:  Sean C Courtney; Leonardo Susta; Dejelia Gomez; Nichole L Hines; Janice C Pedersen; Corrie C Brown; Patti J Miller; Claudio L Afonso
Journal:  J Clin Microbiol       Date:  2012-11-28       Impact factor: 5.948

4.  Newcastle disease virus fusion protein is the major contributor to protective immunity of genotype-matched vaccine.

Authors:  Shin-Hee Kim; Nanchaya Wanasen; Anandan Paldurai; Sa Xiao; Peter L Collins; Siba K Samal
Journal:  PLoS One       Date:  2013-08-28       Impact factor: 3.240

5.  Strategies in gene therapy for glioblastoma.

Authors:  Aneta Kwiatkowska; Mohan S Nandhu; Prajna Behera; E Antonio Chiocca; Mariano S Viapiano
Journal:  Cancers (Basel)       Date:  2013-10-23       Impact factor: 6.639

6.  Avian paramyoxvirus-8 immunization reduces viral shedding after homologous APMV-8 challenge but fails to protect against Newcastle disease.

Authors:  Christian Grund; Constanze Steglich; Eva Huthmann; Martin Beer; Thomas C Mettenleiter; Angela Römer-Oberdörfer
Journal:  Virol J       Date:  2014-10-08       Impact factor: 4.099

7.  Complete genome sequence of a novel avian paramyxovirus isolated from wild birds in South Korea.

Authors:  Jipseol Jeong; Youngsik Kim; Injung An; Seung-Jun Wang; Yongkwan Kim; Hyun-Jeong Lee; Kang-Seuk Choi; Se-Pyeong Im; Wongi Min; Jae-Ku Oem; Weonhwa Jheong
Journal:  Arch Virol       Date:  2017-10-16       Impact factor: 2.574

8.  Novel avian paramyxovirus isolated from gulls in Caspian seashore in Kazakhstan.

Authors:  Kobey Karamendin; Aidyn Kydyrmanov; Yermukhammet Kasymbekov; Saule Asanova; Klara Daulbayeva; Aigerim Seidalina; Elizaveta Khan; Sally M Harrison; Ian M Carr; Simon J Goodman; Alibek Moldakozhayev; Marat Sayatov
Journal:  PLoS One       Date:  2017-12-28       Impact factor: 3.240

9.  Mutations in the fusion protein cleavage site of avian paramyxovirus serotype 4 confer increased replication and syncytium formation in vitro but not increased replication and pathogenicity in chickens and ducks.

Authors:  Shin-Hee Kim; Sa Xiao; Heather Shive; Peter L Collins; Siba K Samal
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

10.  Circulation of avian paramyxoviruses in wild birds of Kazakhstan in 2002-2013.

Authors:  Kobey Karamendin; Aidyn Kydyrmanov; Aigerim Seidalina; Saule Asanova; Klara Daulbayeva; Yermukhammet Kasymbekov; Elizaveta Khan; Sasan Fereidouni; Elke Starick; Kainar Zhumatov; Marat Sayatov
Journal:  Virol J       Date:  2016-02-04       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.